APADAZ
Active substance: BENZHYDROCODONE HYDROCHLORIDE, ACETAMINOPHEN
TABLET · BENZHYDROCODONE HYDROCHLORIDE 6.12 mg/1, ACETAMINOPHEN 325 mg/1
United StatesActive
Marketing holder: Zevra Therapeutics, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BENZHYDROCODONE HYDROCHLORIDE · 6.12 mg/1
- ACETAMINOPHEN · 325 mg/1
Registration
- Registration number
- 70040-0167
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CII
- Route
- ORAL
Sources
- product · openFDA NDC · 70040-0167 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 70040-0167 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 70040-0167 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 70040-0167 · Verified 2026-10-09 · open in source